Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

A Study to Compare the Effectiveness and Safety of Fesoterodine and Placebo in an Elderly Population of Patients Who go to the Toilet Very Frequently Due to Overactive Bladder.

NCT00798434 ·Status: COMPLETED ·Phase: PHASE4

Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.

NCT00561951 ·Status: COMPLETED ·Phase: PHASE2

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212706 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.

NCT03175029 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)

NCT00231790 ·Status: COMPLETED ·Phase: PHASE2

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212732 ·Status: COMPLETED ·Phase: PHASE3

A Study of YM178 in Patients With Symptomatic Overactive Bladder

NCT00527033 ·Status: COMPLETED ·Phase: PHASE2

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01043666 ·Status: COMPLETED ·Phase: PHASE3

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

NCT00170755 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004 ·Status: COMPLETED ·Phase: PHASE3

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

NCT00340704 ·Status: COMPLETED ·Phase: PHASE2

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

NCT00730535 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)

NCT00290563 ·Status: COMPLETED ·Phase: PHASE2

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

NCT00408954 ·Status: COMPLETED ·Phase: PHASE2

Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder

NCT01054222 ·Status: COMPLETED ·Phase: PHASE4

Antibiotic Usage Prior to OnabotulinumtoxinA Injection

NCT04754737 ·Status: RECRUITING ·Phase: NA

Efficacy and Safety of GSK1358820 in Subjects With Overactive Bladder

NCT02820844 ·Status: COMPLETED ·Phase: PHASE3

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

NCT03572231 ·Status: COMPLETED

Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity

NCT00335660 ·Status: TERMINATED ·Phase: PHASE2

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

NCT01099345 ·Status: TERMINATED

Optimizing Overactive Bladder Treatment

NCT03904407 ·Status: COMPLETED ·Phase: NA

Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive Bladder

NCT00171184 ·Status: COMPLETED ·Phase: PHASE4

Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

NCT04305743 ·Status: RECRUITING ·Phase: PHASE4

A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

NCT00749632 ·Status: COMPLETED ·Phase: PHASE2